Tuesday, February 27, 2024
Platform for Therapeutics
VerImmune Inc is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases, with an initial focus on Oncology.
CEO/Top Company Official
Lead Product in Development
Development Phase of Primary Product
Number Of Unlicensed Products
Multiple opportunities for co-discovery